{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:00:15Z","timestamp":1761058815991},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/ogx.0b013e3181706620","type":"journal-article","created":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T07:04:59Z","timestamp":1211439899000},"page":"395-402","source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic Amenorrhea in Patients at Risk for Thrombocytopenia"],"prefix":"10.1097","volume":"63","author":[{"given":"Meredith K.","family":"Martin-Johnston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olanma Y.","family":"Okoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-23-20210212","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1001\/jama.1993.03500140075039","article-title":"Clinical manifestations and treatment of dysfunctional uterine bleeding.","volume":"269","author":"Bayer","year":"1993","journal-title":"JAMA"},{"key":"R2-23-20210212","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1471-0528.1992.tb13758.x","article-title":"The epidemiology of hysterectomy: findings in a large cohort study.","volume":"99","author":"Vessey","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"R3-23-20210212","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/bmj.294.6574.759","article-title":"Menorrhagia.","volume":"294","author":"Rees","year":"1987","journal-title":"BML"},{"key":"R4-23-20210212","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/cncr.22199","article-title":"Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.","volume":"107","author":"Meirow","year":"2006","journal-title":"Cancer"},{"key":"R5-23-20210212","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00277-004-0905-4","article-title":"The spectrum of bleeding disorders in women with menorrhagia: a report from Western India.","volume":"84","author":"Trasi","year":"2005","journal-title":"Ann Hematol"},{"key":"R6-23-20210212","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)08248-2","article-title":"Frequency of inherited bleeding disorders in women with menorrhagia.","volume":"351","author":"Kadir","year":"1998","journal-title":"Lancet"},{"key":"R7-23-20210212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1191\/0961203302lu163oa","article-title":"Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations.","volume":"11","author":"Pasoto","year":"2002","journal-title":"Lupus"},{"key":"R8-23-20210212","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1191\/0961203302lu219oa","article-title":"Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus.","volume":"11","author":"Silva","year":"2002","journal-title":"Lupus"},{"key":"R9-23-20210212","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer Statistics, 2007.","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"R11-23-20210212","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/pbc.20444","article-title":"Cancer in adolescents and young adults aged 15\u201324 years: a report from the north of England young person's Malignant Disease Registry, UK.","volume":"45","author":"Pearce","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R12-23-20210212","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ajh.2830420404","article-title":"Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation.","volume":"42","author":"Ghalie","year":"1993","journal-title":"Am J Hematol"},{"issue":"suppl 1","key":"R13-23-20210212","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/stem.5530140735","article-title":"The role of platelet growth factors in cancer therapy.","volume":"14","author":"Clarke","year":"1996","journal-title":"Stem Cells"},{"key":"R14-23-20210212","first-page":"110","article-title":"Challenges in the development of platelet growth factors: low expectations for low counts.","volume":"1","author":"Brown","year":"2002","journal-title":"Curr Hematol Rep"},{"key":"R15-23-20210212","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2807\/esm.10.02.00521-en","article-title":"Residual risk of transfusion-transmitted viral infections in Spain, 1997\u20132002, and impact of nucleic acid testing.","volume":"10","author":"Alvarez do Barrio","year":"2005","journal-title":"Euro Surveill"},{"key":"R16-23-20210212","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM199512283332601","article-title":"Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.","volume":"333","author":"Lachritz","year":"1995","journal-title":"N Engl J Med"},{"key":"R17-23-20210212","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00062752-199811000-00008","article-title":"Transfusion-transmissible infections.","volume":"5","author":"Vrielink","year":"1998","journal-title":"Curr Opin Hematol"},{"key":"R18-23-20210212","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0037-1963(01)90120-9","article-title":"Bacterial contamination of platelet concentrates: incidence, significance, and prevention.","volume":"38","author":"Blajchman","year":"2001","journal-title":"Semin Hematol"},{"key":"R19-23-20210212","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijgo.2006.02.004","article-title":"Gynaecological and obstetric management of women with inherited bleeding disorders.","volume":"95","author":"Demers","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"R20-23-20210212","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-0528.2004.00305.x","article-title":"The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders.","volume":"111","author":"Kingman","year":"2004","journal-title":"BJOG"},{"key":"R21-23-20210212","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3109\/10428190109097723","article-title":"Prevention of menstruation with leuprorelin (GnRH Agonist) in women undergoing myelosuppresive chemotherapy or radiochemotherapy for hematological malignancies: a pilot study.","volume":"42","author":"Lhomme","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"R22-23-20210212","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bmt.1701187","article-title":"Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation.","volume":"21","author":"Chiusolo","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R23-23-20210212","first-page":"275","article-title":"Therapeutic effect of danazol on metrorrhagia in patients with idiopathic thrombocytopenic purpura (ITP).","volume":"28","author":"Ambriz","year":"1986","journal-title":"Nouv Rev Fr Hematol"},{"key":"R24-23-20210212","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000010118","article-title":"Short-term treatment of uterine fibromyomas with danazol.","volume":"47","author":"De Leo","year":"1999","journal-title":"Gynecol Obstet Invest"},{"key":"R25-23-20210212","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0015-0282(03)00070-0","article-title":"Homodynamic effect of danazol therapy in women with uterine leiomymomata.","volume":"79","author":"La Marca","year":"2003","journal-title":"Fertil Steril"},{"issue":"2","key":"R26-23-20210212","first-page":"CD001017","article-title":"Danazol for heavy menstrual bleeding.","author":"Beaumont","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-23-20210212","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/01443619866336","article-title":"A double-blind randomized study comparing danazol and medroxyprogesterone acetate in the management of menorrhagia.","volume":"18","author":"Dunphy","year":"1998","journal-title":"J Obstet Gynaecol"},{"key":"R28-23-20210212","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2165\/00002018-200225110-00002","article-title":"A benefit-risk assessment of medical treatment for uterine leiomyomas.","volume":"25","author":"De Leo","year":"2002","journal-title":"Drug Saf"},{"key":"R29-23-20210212","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1783\/147118904322995537","article-title":"Modern management of menorrhagia.","volume":"30","author":"Protheroe","year":"2004","journal-title":"J Fam Plann Reprod Health Care"},{"key":"R30-23-20210212","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/107327480301000107","article-title":"Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review.","volume":"10","author":"Van Laar","year":"2003","journal-title":"Cancer Control"},{"key":"R31-23-20210212","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.bmt.1704577","article-title":"Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation.","volume":"34","author":"Amsterdam","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R32-23-20210212","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.fertnstert.2005.04.062","article-title":"Management of excessive menstrual bleeding in women with hemostatic disorders.","volume":"84","author":"Kadir","year":"2005","journal-title":"Fertil Steril"},{"key":"R33-23-20210212","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.291.12.1456","article-title":"Clinical outcomes and costs with the levonorgesterel-releasing intrauterine system or hysterectomy for treatment of menorrhagia.","volume":"291","author":"Hurskainen","year":"2004","journal-title":"JAMA"},{"issue":"19","key":"R34-23-20210212","first-page":"CD002126","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding (review).","author":"Lethaby","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R35-23-20210212","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0010-7824(02)00522-X","article-title":"The effect of a levonorgestrel-releasing intrauterine treatment of myoma-related menorrhagia.","volume":"67","author":"Mercorio","year":"2003","journal-title":"Contraception"},{"key":"R36-23-20210212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000080932","article-title":"The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial.","volume":"59","author":"Soysal","year":"2005","journal-title":"Gynecol Obstet Invest"},{"key":"R37-23-20210212","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2002-32434","article-title":"A randomized controlled trial of levonorgesterel releasing IUD and thermal balloon ablation in the treatment of menorrhagia.","volume":"124","author":"Soysal","year":"2002","journal-title":"Zentralbl Gynakol"},{"key":"R38-23-20210212","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0301-2115(01)00555-3","article-title":"The effect on menstrual blood loss in women with uterine fibroids of a novel \u201cframeless\u201d intrauterine levonorgestrel-releasing drug delivery system: a pilot study.","volume":"102","author":"Wildemeersch","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R39-23-20210212","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus.","volume":"353","author":"Sanchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"key":"R40-23-20210212","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(97)10319-1","article-title":"Complications of use of intrauterine devices among HIV-1-infected women.","volume":"351","author":"Sinei","year":"1998","journal-title":"Lancet"},{"key":"R41-23-20210212","first-page":"726","article-title":"Clinical inquiries. What are contraindications to IUDs?","volume":"55","author":"Paladine","year":"2006","journal-title":"J Fam Pract"},{"key":"R42-23-20210212","first-page":"99","article-title":"Intrauterine contraceptive device failures in renal transplant patients.","volume":"26","author":"Zerner","year":"1981","journal-title":"J Reprod Med"},{"key":"R43-23-20210212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(99)00061-X","article-title":"Effect of the levonorgesterol-releasing intrauterine system on uterine myomas in a renal transplant patient.","volume":"60","author":"Fong","year":"1999","journal-title":"Contraception"},{"key":"R44-23-20210212","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective.","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"key":"R45-23-20210212","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"Use of hormonal contraception in women with coexisting medical conditions. ACOG Practice Bulletin #73.","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R46-23-20210212","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/cncr.11623","article-title":"High incidence of thromboembolism in patients with central nervous system lymphoma.","volume":"98","author":"Golschmidt","year":"2003","journal-title":"Cancer"},{"key":"R47-23-20210212","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2004.07.016","article-title":"Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis.","volume":"115","author":"Ziegler","year":"2005","journal-title":"Thromb Res"},{"key":"R48-23-20210212","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/1097-0142(20000801)89:3<640::AID-CNCR20>3.0.CO;2-E","article-title":"The risk of venous thromboembolism is increased throughout the course of malignant glioma.","volume":"89","author":"Marras","year":"2000","journal-title":"Cancer"},{"key":"R49-23-20210212","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1067\/mva.2003.191","article-title":"Factors associated with recurrent venous thromboembolism in patients with malignant disease.","volume":"37","author":"Lin","year":"2003","journal-title":"J Vasc Surg"},{"key":"R50-23-20210212","article-title":"World Health Organization: improving access to quality care in family planning. Medical Criteria for Contraceptive Use. 3rd ed.","year":"2004"},{"key":"R51-23-20210212","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0167-8140(02)00003-8","article-title":"Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer\u2014a retrospective review of Chinese patients and comparison with an historic Western series.","volume":"62","author":"Ma","year":"2002","journal-title":"Radiother Oncol"},{"key":"R52-23-20210212","first-page":"229","article-title":"Contraception in women with special medical needs.","volume":"24","author":"Neinstein","year":"1998","journal-title":"Compr Ther"},{"key":"R53-23-20210212","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0146-0005(98)80050-5","article-title":"Contraception in the patient with liver disease.","volume":"22","author":"Connolly","year":"1998","journal-title":"Semin Perinatol"},{"key":"R54-23-20210212","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0010-7824(97)00141-8","article-title":"The contraceptive choice for a wilson's disease patient with chronic liver disease.","volume":"56","author":"Haimov-Kochman","year":"1997","journal-title":"Contraception"},{"key":"R55-23-20210212","first-page":"653","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial.","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R56-23-20210212","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter randomized study of an extended cycle oral contraceptive.","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"R57-23-20210212","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.whi.2004.08.005","article-title":"Evidence about extending the duration of oral contraceptive use to suppress menstruation.","volume":"14","author":"Hitchcock","year":"2004","journal-title":"Womens Health Issues"},{"key":"R58-23-20210212","first-page":"558","article-title":"Clinical Gynecologic Endocrinology and Infertility. 7th ed.","author":"Speroff","year":"2005"},{"key":"R59-23-20210212","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00006254-200202000-00024","article-title":"Noncontraceptive health benefits of intrauterine devices: a systemic review.","volume":"57","author":"Hubacher","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"R60-23-20210212","first-page":"74","article-title":"The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systemic review.","volume":"108","author":"Stewart","year":"2001","journal-title":"BJOG"},{"key":"R61-23-20210212","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/bmj.316.7138.1122","article-title":"Open randomized study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy.","volume":"316","author":"Lahteenmaki","year":"1998","journal-title":"BMJ"},{"key":"R62-23-20210212","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1471-0528.1998.tb10172.x","article-title":"Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.","volume":"105","author":"Irvine","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R63-23-20210212","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0015-0282(01)01909-4","article-title":"Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection.","volume":"76","author":"Istre","year":"2001","journal-title":"Fertil Steril"},{"key":"R64-23-20210212","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0301-2115(99)00217-1","article-title":"Prospective comparison study of levonorgestrel IUD versus Roller-Ball endometrial ablation in the management of refractory recurrent hypermenorrhea.","volume":"90","author":"Romer","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R65-23-20210212","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijgo.2007.01.009","article-title":"Efficacy, acceptability, and side effects of the levonorgestrel intrauterine system for menorrhagia.","volume":"97","author":"Kriplani","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"R66-23-20210212","first-page":"47","article-title":"Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management.","volume":"20","author":"Kaunitz","year":"2007","journal-title":"Manag Care Interface"},{"key":"R67-23-20210212","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00001703-200412000-00009","article-title":"Levonorgestrel-releasing intrauterine system in the treatment of heavy bleeding.","volume":"16","author":"Hurskainen","year":"2004","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R68-23-20210212","first-page":"229","article-title":"Hysterectomy rates in the United States 1990\u20131997.","volume":"99","author":"Farquhar","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R69-23-20210212","article-title":"Health\u2014United States, 1995.","year":"1995"},{"key":"R70-23-20210212","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.0001-6349.2005.0414d.x","article-title":"Puberty menorrhagia secondary to inherited bleeding disorders.","volume":"84","author":"Leung","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R71-23-20210212","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1471-0528.1999.tb08275.x","article-title":"A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcomes at four years.","volume":"106","year":"1999","journal-title":"BJOG"},{"key":"R72-23-20210212","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000265805.76453.33","article-title":"Global endometrial ablation for menorrhagia in women with bleeding disorders.","volume":"109","author":"El-Nashar","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R73-23-20210212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJM199607183350302","article-title":"Endometrial resection for the treatment of menorrhagia.","volume":"335","author":"O'Connor","year":"1996","journal-title":"N Engl J Med"},{"key":"R74-23-20210212","first-page":"1","article-title":"Hysterectomy surveillance\u2014United States, 1994\u20131999.","volume":"51","author":"Keshavarz","year":"2002","journal-title":"MMWR Surveill Summ"}],"container-title":["Obstetrical &amp; Gynecological Survey"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006254-200806000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:28:27Z","timestamp":1618036107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006254-200806000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ogx.0b013e3181706620","relation":{},"ISSN":["0029-7828"],"issn-type":[{"value":"0029-7828","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}